Gal Yerushalmi

686 citations
12 papers · 535 indexed · h-index 11
Topics
Escherichia coli research studies (5 papers)Viral gastroenteritis research and epidemiology (4 papers)Vibrio bacteria research studies (4 papers)

In The Last Decade

Gal Yerushalmi

12 papers receiving 531 citations

Peers

Gal Yerushalmi
Comparison fields: 5 of 65
  • Endocrinology 316
  • Molecular Biology 219
  • Genetics 153
  • Infectious Diseases 109
  • Immunology 74
Replace Eugenia Silva‐Herzog with:
Eugenia Silva‐Herzog United States
Sahar H. El‐Etr United States
Sonia Mondino France
Michael J. Gubbins Canada
Ethel Bayer‐Santos Brazil
Ascel Samba‐Louaka France
Christian González‐Rivera United States
Marion S. Dorer United States
Philip Ozersky United States
Tadhg Ó Cróinı́n Ireland
Gal Yerushalmi relative to Eugenia Silva‐Herzog United States Eugenia Silva‐Herzog's profile →
Citations per field
00.5×2.6×
Eugenia Silva‐Herzog · 1×
Citations per year

Countries citing papers authored by Gal Yerushalmi

Since Specialization
Citations

This map shows the geographic impact of Gal Yerushalmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Yerushalmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Yerushalmi more than expected).

Fields of papers citing papers by Gal Yerushalmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Yerushalmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Yerushalmi. The network helps show where Gal Yerushalmi may publish in the future.

Co-authorship network of co-authors of Gal Yerushalmi

This figure shows the co-authorship network connecting the top 25 collaborators of Gal Yerushalmi. A scholar is included among the top collaborators of Gal Yerushalmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Yerushalmi. Gal Yerushalmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 20
3 40
4 19
5 28
6 58
7 153
8 25
9 37
10 31
11 23
12 100

About Gal Yerushalmi

Gal Yerushalmi is a scholar working on Endocrinology, Molecular Medicine and Infectious Diseases, having authored 12 papers that have together received 535 indexed citations. Recurring topics across this work include Escherichia coli research studies (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and Vibrio bacteria research studies (4 papers). The work is most often cited by research in Endocrinology (316 citations), Molecular Medicine (73 citations) and Parasitology (51 citations). Gal Yerushalmi has collaborated with scholars based in Israel, Singapore and United Kingdom. Frequent co-authors include Gil Segal, Tal Zusman, Ilan Rosenshine, Ehud Banin, Chen Nadler, Kobi Baruch, Eitan Shaulian, Raz Zarivach, Orli Yogev and Yinon Ben‐Neriah. Their work appears in journals such as The EMBO Journal, PLoS ONE and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026